Tenthpin Management Consultants
Making a Difference in Clinical Trials

As the pharmaceutical sector moves towards patient-centric treatments and improving the overall patient experience, its status quo is undergoing great disruption. The pharma landscape is leveraging technological advancements to enable products and service offerings to go beyond the medicine and focus on prevention, diagnostics, and cure. This has resulted in the introduction of personalised treatments and a growing number of new product launches in the pharma space. As organisations in the pharma and life sciences arena design, implement and introduce patient-centric value chains, clinical trials play a significant role in this evolution. Today, with the world battling the pandemic challenge, technology innovation in clinical trials has become the need of the hour for the pharma space. However, clinical trial designs are becoming more complex and challenging due to trials becoming smaller, higher competition on patient enrollment and an increased effect of non-adherence. With a strong focus on delivering innovation to the life sciences industry and all its different segments, which include pharma, biotech, medical devices, animal health and clinical research through its state-of-the-art offerings, Tenthpin Management Consultants has a solution to these roadblocks.

Spearheaded by a group of five veterans who combined their deep industry and business experience with extensive technological know-how, Tenthpin is revolutionising the life sciences industry and clinical trial landscape with its extensive solutions and services portfolio. The company works with clinical research organisations as a neutral advisor and offers them unbiased, strategic ideas to approach their business challenges. “We help clients understand their business challenges and aid them in leveraging the right technology and strategy in clinical trials to stay ahead in the life sciences and clinical space,” says Michael Schmidt, Co-Founder, Partner and Board Member of Tenthpin. The flexibility and adaptability that Tenthpin offers through its toolset comprising varying technologies helps the company respond to distinct customer requirements.

Together with Roche and SAP, Tenthpin is driving a co-innovation consortium with the pharma industry to build an integrated, next generation Clinical Trials Supply Management (CTSM) solution

Michael points out how clients in the clinical trial supply space experience challenges in inventory management and tracking on sites and with physicians. The absence of a single source of truth or technology that can be integrated with clinical trial supply management systems to serve as a planning base and support the end-to-end supply chain makes the task even more arduous. “Together with Roche and SAP, Tenthpinis driving a co-innovation consortium with the pharma industry to build an integrated, next generation Clinical Trials Supply Management (CTSM) solution,” remarks Michael. The company is taking the clinical trial arena to the next level of progress with regards to clinical trial supply and standardization.

To help clients, especially in the clinical space, stay competitive, Tenthpin engages with them and conducts short term assignments, which span between two to four weeks, to derive insights from their business processes. The team then examines the client’s existing range of product offerings, their KPIs, the technology trends, and subsequently develops a strategy for their journey forward. After the implementation and execution of the strategy, the company further assists the client in their business process or technological-enabled transformation of clinical trials. Additionally, Tenthpin does the design and implementation of solutions for different clients.

Michael believes that Tenthpin’s innovative and disruptive solutions have widened its ability to partner with several startups not only focused on the life sciences sector but also in the clinical space. To offer a clearer understanding of Tenthpin’s offerings, Michael proceeds to narrate how the company is implementing a highly disruptive clinical e-labeling solution with a U.S-based pharma company to improve clinical processes. Another idea that the company is bringing to the forefront is the introduction of electronic patient information (ePI) and digital leaflets.

Tenthpin, with its advanced technologies, has carved a niche for itself in the clinical trial space, especially with the current pandemic crisis, increasing its demand in the marketplace. The company has expanded its reach across the U.S, European, and Asian markets, and is anticipating greater growth globally in the months ahead. “We do not just offer operational expertise to clients, we give them a wholesome experience on their journey forward,” concludes Michael.